January 7, 2020
Learn about DRSC/TRiP activities focused on using CRISPR activation to develop human disease models in a recently published Q&A with our Director, Dr. S.E. Mohr, who will be a speaker this spring at an upcoming genome editing conference in Boston, MA.
Also of recent interest -- this article in Lab Animal on CRISPR screens, which features discussion with Drosophila CRISPR pooled screen technology developer Dr. R. Viswanatha.